• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

TNGN:US

0.1610 USD 0.0190 10.56%

As of 20:10:00 ET on 07/24/2014.

Snapshot for Tengion Inc (TNGN)

Open: 0.1790 Day's Range: 0.1600 - 0.1790 Volume: 40,527
Previous Close: 0.1800 52wk Range: 0.1522 - 1.0400 1-Yr Rtn: -81.70%

Stock Chart for TNGN

No chart data available.
  • TNGN:US 0.1610
  • 1D
  • 1M
  • 1Y
0.1800
Interactive TNGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TNGN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -6.3000
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 3.52
Shares Outstanding (M) 21.85
30 Day Average Volume 34,646
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TNGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TNGN

Tengion Inc. is a regenerative medicine company focused on discovering, developing, manufacturing and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues. The Company currently creates functional neo-organs and neo-tissues using a patient's own cells, or autologous cells, in conjunction with its Organ Regeneration Platform.

John L MiclotPresident/CEOTimothy Bertram "Tim"Pres:Rsch & Dev/Chief Scientific Ofcr
A Brian DavisSenior VP:Finance/CFO/Secretary
More Company Profile & Key Executives for TNGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil